Stem Cell Therapy Success Rates Hit 78%: New Research Reveals Breakthrough Results Frequently Asked Questions Introduction The global stem cell therapy market is on track to reach $928.6 million by 2031, driven by groundbreaking treatments and
Tag: Multiple Sclerosis
Ocrelizumab Effectiveness In Multiple Sclerosis
Ocrelizumab Effectiveness In Multiple Sclerosis Overview Throughout its clinical development program, ocrelizumab has consistently demonstrated efficacy in enhancing clinical outcomes for multiple sclerosis, encompassing annualized relapse rates and confirmed disability progression. Despite these positive findings, the translation of this efficacy into real-world clinical practice remained uncertain. This study aimed to systematically compile
LEAP-MS: Adaptions for Advanced Stages
LEAP-MS: Adaptions for Advanced Stages Lifestyle, Exercise and Activity Package for People Living with Progressive Multiple Sclerosis (LEAP-MS): adaptations for remote delivery & improved efficiency Multiple sclerosis (MS) is the most common neurologic disorder of young and middle-aged adults. MS expresses itself in four clinical forms: relapsing-remitting MS (RRMS), secondary progressive MS
MS: Exercise Impacts on MRI
MS: Exercise Impacts on MRI Multiple sclerosis (MS) is a chronic condition that affects the optic nerves, spinal cord, and brain. Symptoms of MS include body tingling, numbness, weakness, and poor vision. Other uncommon symptoms include cognitive problems, urinary issues, and muscle stiffness. The problem with most cases of MS is it's
